Di Fronzo G - Search Results

1

Cell kinetics as a prognostic indicator in node-negative breast cancer.

Silvestrini R, Daidone MG, Valagussa P, Di Fronzo G, Mezzanotte G, Bonadonna G. Silvestrini R, et al. Among authors: di fronzo g. Eur J Cancer Clin Oncol. 1989 Aug;25(8):1165-71. doi: 10.1016/0277-5379(89)90410-0. Eur J Cancer Clin Oncol. 1989. PMID: 2767105

2

3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.

Silvestrini R, Daidone MG, Valagussa P, Di Fronzo G, Mezzanotte G, Mariani L, Bonadonna G. Silvestrini R, et al. Among authors: di fronzo g. J Clin Oncol. 1990 Aug;8(8):1321-6. doi: 10.1200/JCO.1990.8.8.1321. J Clin Oncol. 1990. PMID: 2380758

3

Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer.

Silvestrini R, Daidone MG, Luisi A, Boracchi P, Mezzetti M, Di Fronzo G, Andreola S, Salvadori B, Veronesi U. Silvestrini R, et al. Among authors: di fronzo g. J Clin Oncol. 1995 Mar;13(3):697-704. doi: 10.1200/JCO.1995.13.3.697. J Clin Oncol. 1995. PMID: 7884430

4

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F, Veronesi U. Silvestrini R, et al. Among authors: di fronzo g. J Natl Cancer Inst. 1994 Apr 6;86(7):499-504. doi: 10.1093/jnci/86.7.499. J Natl Cancer Inst. 1994. PMID: 8133533

5

Prognostic significance of proliferative activity and ploidy in node-negative breast cancers.

Silvestrini R, Daidone MG, Del Bino G, Mastore M, Luisi A, Di Fronzo G, Boracchi P. Silvestrini R, et al. Among authors: di fronzo g. Ann Oncol. 1993 Mar;4(3):213-9. doi: 10.1093/oxfordjournals.annonc.a058458. Ann Oncol. 1993. PMID: 8471553 Free article.

6

p53 as an independent prognostic marker in lymph node-negative breast cancer patients.

Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U. Silvestrini R, et al. Among authors: di fronzo g. J Natl Cancer Inst. 1993 Jun 16;85(12):965-70. doi: 10.1093/jnci/85.12.965. J Natl Cancer Inst. 1993. PMID: 8496982

7

Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy.

Silvestrini R, Daidone MG, Mastore M, Di Fronzo G, Coradini D, Boracchi P, Squicciarini P, Salvadori B, Veronesi U. Silvestrini R, et al. Among authors: di fronzo g. J Clin Oncol. 1993 Jun;11(6):1150-5. doi: 10.1200/JCO.1993.11.6.1150. J Clin Oncol. 1993. PMID: 8501501

8

int-2 oncogene amplification and prognosis in node-negative breast carcinoma.

Fioravanti L, Cappelletti V, Coradini D, Miodini P, Borsani G, Daidone MG, Di Fronzo G. Fioravanti L, et al. Among authors: di fronzo g. Int J Cancer. 1997 Dec 19;74(6):620-4. doi: 10.1002/(sici)1097-0215(19971219)74:6<620::aid-ijc11>3.0.co;2-9. Int J Cancer. 1997. PMID: 9421359

9

Biological characterisation of primary and metachronous lesions in breast cancer patients.

Silvestrini R, Valentinis B, Daidone MG, Di Fronzo G, Coradini D, Salvadori B. Silvestrini R, et al. Among authors: di fronzo g. Eur J Cancer. 1992;28A(12):2006-10. doi: 10.1016/0959-8049(92)90249-2. Eur J Cancer. 1992. PMID: 1419299

10

Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer.

Cappelletti V, Coradini D, Scanziani E, Benini E, Silvestrini R, Di Fronzo G. Cappelletti V, et al. Among authors: di fronzo g. Eur J Cancer. 1992;28A(8-9):1315-8. doi: 10.1016/0959-8049(92)90507-x. Eur J Cancer. 1992. PMID: 1515241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters